Modern diagnostic and treatment aspects of diabetic macular edema

Modern diagnostic and treatment aspects of diabetic macular edema

Diabetic macular oedema (DMO) is the leading cause of vision loss and disability in working-age people with diabetes mellitus. This literature review describes pathogenetic mechanisms, concepts, diagnostic techniques and capabilities of novel laser technologies in the treatment of DMO. In recent yea...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alexander Viktorovich Doga, Galina Fedorovna Kachalina, Elena Konstantinovna Pedanova, Dmitriy Anatol'evich Buryakov
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2014-12-01
Series:	Сахарный диабет
Subjects:	diabetic macular oedema microperimetry subthreshold micropulse laser treatment
Online Access:	https://www.dia-endojournals.ru/jour/article/view/6689
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comparison of efficacy and safety of the combined laser treatment technology versus conventional laser photocoagulation in diabetic macular edema management
by: Aleksander Victorovich Doga, et al.
Published: (2017-05-01)

Subthreshold micropulse green laser versus yellow laser in the treatment for chronic central serous chorioretinopathy
by: Mohamad G. Zeinalabdeen, et al.
Published: (2025-01-01)

Impact of Subthreshold Micropulse Laser on the Vascular Network in Diabetic Macular Edema: An Optical Coherence Tomography Angiography Study
by: Barbara Sabal, et al.
Published: (2025-05-01)

The safe lowest effective power of subthreshold micropulse laser treatment in Chinese patients with acute or chronic central serous chorioretinopathy
by: Ting Xie, et al.
Published: (2024-11-01)

The Effects of Slow-Release Dexamethasone in the Treatment of Diabetic Macular Edema
by: Enzo Maria Vingolo, et al.
Published: (2025-01-01)

Analysis of the central zone of the retina in patients with diabetic macular edema
by: Mukharram Muhtaramovich Bikbov, et al.
Published: (2015-12-01)

Prospective Evaluation of Results of Surgical Treatment of Patients with Idiopathic Macular Hole by Phacovitrectomy and Combined Cataract and Vitrectomy Surgery
by: Kinga Tochman-Kanty, et al.
Published: (2024-05-01)

Functional and anatomical results of subthreshold micropulse laser as rescue treatment for central serous chorioretinopathy after verteporfin shortage
by: Carlos Oribio-Quinto, et al.
Published: (2024-10-01)

Recent Innovations in Retinal Laser Therapy
by: Mi Zheng, et al.
Published: (2025-02-01)

A variant of combined treatment for chronic central serous chorioretinopathy complicated by type 1 choroidal neovascularization
by: A. V. Tereshchenko, et al.
Published: (2023-03-01)

Subthreshold micro-impulse laser coagulation of retinal detachment in children
by: Н. A. Sushchenia, et al.
Published: (2020-12-01)

A randomized non-inferiority trial of 577nm subthreshold micropulse laser versus half-dose photodynamic therapy for acute central serous chorioretinopathy
by: Lijun Zhou, et al.
Published: (2024-02-01)

Real-world use of a hydrophilic curcumin-based oral formulation in the management of macular oedema: a collection of clinical experiences
by: Davide Allegrini, et al.
Published: (2025-05-01)

Combined Technique and Its Clinical and Pathogenetic Evaluation in Treatment of Central Serous Chorioretinopathy Using Subthreshold Microimpulse Laser Irradiation with a Wavelength of 577 nm in Combination with Injections of Platelet Autoplasma
by: O. M. Stanishevskaya, et al.
Published: (2019-08-01)

Occult Macular Dystrophy
by: Işıl Sayman Muslubaş, et al.
Published: (2016-04-01)

Role of Microperimetry in Observation and Treatment in Patients with Macular Holes
by: A. S. Zotov, et al.
Published: (2021-04-01)

The clinical evaluation of the effectiveness of various minimally invasive methods in the treatment of central serous chorioretinopathy
by: A. F. Yusupov, et al.
Published: (2025-04-01)

Functional results of surgical treatment of macular holes fully preserving the internal limiting membrane as compared with the traditional method
by: P. V. Lyskin, et al.
Published: (2023-12-01)

Micropulse transcleral laser cycloplasty (mTLC) should replace the term “micropulse cyclophotocoagulation (mCPC)”
by: I. E. Ioshin
Published: (2024-10-01)

Plasma and Urine Metabolites Associated with Microperimetric Retinal Sensitivity in Age-Related Macular Degeneration
by: Krupa Sourirajan, et al.
Published: (2025-03-01)

Effect of Subthreshold Nanosecond Laser on Loss of OCT Outer Retinal Bands in Age-Related Macular Degeneration: A LEAD Study Report
by: Robyn H. Guymer, MBBS, PhD, et al.
Published: (2025-11-01)

A pilot study : retinal sensitivity change in neovascular age-related macular degeneration patients with better baseline visual acuity
by: Jae Hyup Lee, et al.
Published: (2024-11-01)

Onset of End-Stage Atrophic Age-Related Macular Degeneration as an End Point—A Delphi Study: Classification of Atrophy Meetings Report 7
by: Zhichao Wu, BAppSc(Optom), PhD, et al.
Published: (2025-09-01)

Therapeutic interventions for chronic central serous chorioretinopathy: a comprehensive assessment of systematic reviews
by: Henok Getahun, et al.
Published: (2025-03-01)

A Prospective Interventional Study to Find the Effectivity of Razumab by Measuring Macular Oedema before and after Intravitreal Injection
by: V.K Malathi, et al.
Published: (2025-01-01)

Effects of Dexamethasone Intravitreal Implant on Multifocal Electroretinography in Diabetic Macular Oedema
by: Tranos P, et al.
Published: (2024-11-01)

Modern aproaches to diabetic macular edema diagnosticks
by: A. V. Doga, et al.
Published: (2020-08-01)

Retinal sensitivity above macular neovascularization under anti-VEGF therapy in exudative neovascular age-related macular degeneration
by: Laurenz Pauleikhoff, et al.
Published: (2025-03-01)

Exploiting Microperimetry as a Functional End Point in Healthy Aging and Different Stages of Age-Related Macular Degeneration
by: Johannes Schrittwieser, MD, et al.
Published: (2025-11-01)

Prospects for the treatment of diabetic retinopathy: Modulation of endothelial growth factor
by: Anatoliy Gennad'evich Kuzmin, et al.
Published: (2009-06-01)

Current Approach to Treatment for Central Serous Chorioretinopathy. Review
by: A. K. Drakon, et al.
Published: (2021-10-01)

Visual Acuity Outcomes and Influencing Factors in a Cohort of UK Real-World Diabetic Macular Oedema Patients During the First Two Years of Anti-VEGF Treatment
by: Qing Wen, et al.
Published: (2025-01-01)

OCT-Defined Atrophic Age-Related Macular Degeneration Changes Associated with Deep Visual Sensitivity Losses: A Multicenter Study
by: Zhichao Wu, BAppSc(Optom), PhD, et al.
Published: (2025-11-01)

Real-world outcomes of early and deferred anti-VEGF treatment in diabetic macular oedema in patients with type 1 diabetes
by: Joonas Wirkkala, et al.
Published: (2025-12-01)

Comparison of treatment outcomes between slow coagulation transscleral cyclophotocoagulation and micropulse transscleral laser treatment
by: Young Hoon Hwang, et al.
Published: (2024-10-01)

Baseline factors affecting diabetic macular oedema resolution after intravitreal dexamethasone implant treatment: post hoc analysis of the MEAD study
by: Carolina C. S. Valentim, et al.
Published: (2025-07-01)

Immunological Aspects of Macular Edema after Cataract Surgery in Patients with Diabetes Mellitus
by: M. A. Frolov, et al.
Published: (2019-01-01)

How intravitreal anti-vascular endothelial growth factor initial dosing impacts patient outcomes in diabetic macular oedema
by: Rishi P. Singh, et al.
Published: (2024-12-01)

Use of a multifocal electroretinogram to evaluate the therapeutic effect of a single intravitreal dexamethasone implant, Ozurdex®, for refractory diabetic macular oedema
by: Aya Refaat Ali Mohammed, et al.
Published: (2025-03-01)

Macular perfusion, thickness, and sensitivity in phacovitrectomy versus lens-sparing vitrectomy in rhegmatogenous retinal detachment
by: Ahmed A Abdel Kader, et al.
Published: (2024-07-01)